Tempus ECG-Low EF vs iCAC Device
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is to quickly identify patients 40 years or older who may be at risk for heart failure, leveraging readily available 12-lead ECG data. This tool is ideal for clinical settings where an ECG is a routine part of evaluation and you need an AI-powered binary output to flag individuals for further, more definitive LVEF assessment.
View Tempus ECG-Low EF →Choose iCAC Device if…
Choose Bunkerhill Health's iCAC Device if you aim to opportunistically assess cardiovascular disease risk by analyzing existing routine, non-contrast chest CT scans. This tool is best suited for leveraging previously acquired imaging data to detect and quantify coronary artery calcium, providing valuable adjunctive information to radiologists for early cardiovascular risk stratification without requiring additional dedicated scans.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | iCAC Device |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF provides a straightforward binary output (Low LVEF Detected / Not Detected), which simplifies interpretation and action for a wider range of clinicians. While iCAC offers detailed quantitative and visual data, its complexity may require more specialized radiological expertise for full utilization.
Clinical Value
iCAC DeviceWhile both are FDA-cleared and offer significant clinical value, Bunkerhill Health's iCAC Device excels in opportunistic screening, leveraging existing non-contrast chest CT scans to detect and quantify coronary artery calcium. This approach identifies at-risk patients for cardiovascular disease without requiring additional imaging or patient burden, maximizing the utility of routine data.
Pricing & Value
TieBoth Tempus ECG-Low EF and Bunkerhill Health's iCAC Device have opaque pricing models, requiring direct contact with the vendor for details. Without specific pricing information or publicly available cost-effectiveness studies for either tool, it is not possible to determine which offers superior value.
Enterprise Readiness
Tempus ECG-Low EFTempus AI is a larger, publicly traded company with explicitly stated HIPAA compliance and BAA availability in its published specifications, indicating a mature and transparent approach to enterprise requirements. While Bunkerhill Health has strong deployments in major health systems and claims compliance, its initial specifications were less explicit regarding BAA and HIPAA.
Innovation
iCAC DeviceBunkerhill Health's iCAC Device demonstrates superior innovation through its opportunistic screening approach, detecting coronary artery calcium from routine CT scans already performed for other reasons. This maximizes the value of existing data and avoids additional patient burden. Furthermore, its Carebricks platform enables health systems to rapidly design and deploy custom AI agents across various clinical and operational workflows.
Support & Docs
Tempus ECG-Low EFTempus AI provides clear contact information for customer support via email and phone, and mentions documentation for its other AI products, indicating established support channels. Bunkerhill Health's information does not explicitly detail its customer support channels or documentation availability.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | iCAC Device |
|---|---|---|
| Name | Tempus ECG-Low EF | iCAC Device |
| Company | Tempus AI | Bunkerhill Health |
| Description | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Target Data Type | 12-lead ECG recordings | Routine, non-contrast, non-gated chest CT scans |
| Key Detection/Analysis | Signs of low Left Ventricular Ejection Fraction (LVEF u226440%) | Presence and quantity of coronary artery calcium (CAC) |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and iCAC Device.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or iCAC Device
Backers
Who funded each tool's parent company.